CAS NO: | 2133499-85-9 |
生物活性 | HSP27 inhibitor J2 (J2) is aHSP27inhibitor, which significantly induces abnormal HSP27 dimer formation and inhibits a production of HSP27 giantpolymers, thereby having an effect of inhibiting a chaperone function of the HSP27 and reducing a cell protection function thereof. HSP27 inhibitor J2 (J2) remarkably enhances the antiproliferative activity of 17-AAG and sensitizes cisplatin-induced lungcancercell growth inhibition[1][2]. | ||||||||||||||||
IC50& Target | HSP27[2] | ||||||||||||||||
体外研究 (In Vitro) | HSP27 inhibitor J2 (10 μM; 12 h) induces significant abnormal HSP27 dimer formation in NCI-H460[1]. | ||||||||||||||||
分子量 | 264.30 | ||||||||||||||||
性状 | Solid | ||||||||||||||||
Formula | C13H12O4S | ||||||||||||||||
CAS 号 | 2133499-85-9 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 |
| ||||||||||||||||
溶解性数据 | In Vitro: DMSO : 20 mg/mL(75.67 mM;Need ultrasonic) 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 In Vivo: 请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照In Vitro方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用;
以下溶剂前显示的百
*以上所有助溶剂都可在本网站选购。 |
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024 |